The Metabolic Link

Welcome to The Metabolic Link, a medical and science podcast that explores the common thread of metabolism in health and disease. Join Dr. Dominic D'Agostino PhD, Dr. Angela Poff PhD, and Victoria Field as they dive into the latest research on metabolic health and therapy alongside some of the world’s leading experts. They'll also discuss how this science is being applied in the real world. This is where science meets society.

The Metabolic Link is a health podcast hosted by Unknown Host, with 101 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts The Metabolic Link, a health show with 101 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  The Metabolic Link

  Implementation of Ketogenic and Low Carbohydrate Therapies for Metabolic Disease | Franziska Spritzler, RD, CDE | The Metabolic Link Ep. 101

  Aug 11, 202655 min

  Ketogenic and low-carbohydrate diets often focus on a specific carbohydrate target: keep your net carbs under 30 grams. But as registered dietitian and certified diabetes educator Franziska Spritzler demonstrates in this presentation from Metabolic Health Summit, a carbohydrate target is not a therapy. Effective implementation means a full assessment of medical history, medications, labs, food preferences, lifestyle, and the motivation that will carry a patient through year one and beyond. Spritzler specializes in low-carbohydrate and ketogenic nutrition and has extensive experience helping people use these approaches to improve metabolic health. The creator of lowcarbdietitian.com , she walks through the practical decisions clinicians face: when a ketogenic diet is warranted versus a more flexible low-carbohydrate approach, why she recommends 1.2 to 1.8 grams of protein per kilogram rather than the RDA's 0.8, how to manage medication adjustments for patients at risk of hypoglycemia or hypotension, and how to handle electrolytes, carbohydrate counting, sweeteners, and plant-based variations without losing the patient along the way. Questions Answered in This Episode: • What actually separates a ketogenic diet from a low-carbohydrate diet, and when does the difference matter? • Why is the protein RDA too low for long-term metabolic health, and what range does Spritzler recommend instead? • Who should avoid ketogenic diets entirely, and why are most contraindications manageable with closer supervision? • How should medications be monitored and adjusted when a patient begins carbohydrate restriction? • Should patients count net carbs or total carbs, and why are packaged "net carb" labels unreliable? • Can a ketogenic diet be done as a vegetarian or vegan? A practice-tested blueprint for turning carbohydrate restriction from a prescription into a therapy patients can sustain. Special thanks to the sponsors of this episode: ✅ Genova Connect: Get 15% off any Genova Connect test kit with code METABOLICLINK here . ✅ iRestore: Get a special discount on the iRestore Illumina Face Mask with code LINK here . ✅ fatty15: Get an additional 50% off a 90-day subscription starter kit with code METABOLICLINK . ✅ Zocdoc: Find and instantly book a top-rated doctor here . More Links • Franziska's website: lowcarbdietitian.com • The Metabolic Initiative (expert lectures, CME, ad-free episodes, live Q&As; first 7 days free): membership.metabolicinitiative.com In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in! You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel ! In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in! You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel ! Find us on social: Instagram Facebook YouTube LinkedIn Please keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.

  ListenShow Notes
• 

  Episode #100

  Ben Bikman, PhD | Rethinking Metabolic Health: Insulin, Ketones, and What Comes Next | The Metabolic Link Ep. 100

  Jul 28, 20261h 6m

  For the 100th episode of The Metabolic Link, Ben Bikman, PhD, professor of cell biology and physiology at Brigham Young University and author of Why We Get Sick, returns for a milestone conversation with co-hosts Dominic D’Agostino, PhD, and Victoria Field. Together, they examine what clinicians are measuring, what conventional approaches may be missing, and how the science of metabolic health continues to evolve. Bikman argues that the clinical picture of metabolic health remains glucose-centric and lipid-heavy while the earliest signal, elevated insulin, goes unmeasured. He explains why women stay insulin sensitive at far higher body fat than men and what menopause takes away, why visceral fat is misunderstood, and how a fatty liver can be miscounted as lean mass on a DEXA scan. That last point is why he now says he was wrong about GLP-1 drugs, and why he thinks they should be prescribed as something other than weight loss medication. Questions Answered in This Episode: • Why does standard bloodwork detect metabolic dysfunction so late? • Why are women more insulin sensitive than men at the same or higher body fat? • What actually changes metabolically during menopause? • Is visceral fat inherently dangerous, or is something else going on? • Why did Dr. Bikman change his position on GLP-1 medications? • Should GLP-1 drugs be prescribed as weight loss drugs at all? This milestone episode offers a rigorous, physiology-first look at where metabolic science stands today, and what researchers and clinicians may need to examine next. Thank you for listening, watching, sharing these conversations, and helping us reach 100 episodes. We’re incredibly grateful to have you as part of this community. Special thanks to the sponsors of this episode: Genova Connect: Get 15% off any Genova Connect test kit with code METABOLICLINK here . Cowboy Colostrum: Get up to 25% off with code METABOLIC here . iRestore: Get a special discount on the iRestore Illumina face mask with code LINK here . More Links Dr. Ben Bikman's website: benbikman.com Insulin IQ: insuliniq.com YouTube: youtube.com/@benbikman Instagram: @benbikmanphd Featured study: White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in! You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel ! Find us on social: Instagram Facebook YouTube LinkedIn Please keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.

  ListenShow Notes
• 

  Episode #98

  Ozempic, Insulin Resistance, and Type 2 Diabetes: What Are We Missing? | Dr. Mariela Glandt | The Metabolic Link Ep. 98

  Jun 30, 20261h 5m

  Attend a Live Q&A with Dr. Glandt. Reigster here. What if the way we treat type 2 diabetes is fundamentally backwards? Dr. Mariela Glandt is an endocrinologist and obesity medicine specialist who spent 15 years practicing conventional medicine before concluding, in her words, that how we treat diabetes “is actually upside down.” As co-founder of OwnaHealth, she focuses on addressing the insulin resistance underlying type 2 diabetes, not only the elevated blood sugar it eventually causes. In this episode, she walks through the science of that shift: why fasting insulin may reveal metabolic dysfunction before A1C becomes abnormal, why a laboratory “normal” range running up to 20 can be misleading, and why she believes repeatedly escalating insulin can contribute to weight gain, reduced insulin responsiveness, and worsening metabolic health. She also shares what she has learned bringing low-carbohydrate and ketogenic therapy to underserved communities in the South Bronx, where patients may be navigating severe diabetes alongside financial pressure, cultural food traditions, psychiatric illness, chronic stress, and conflicting medical advice. Her work shows that these therapies can succeed even in communities facing significant barriers to care. Dr. Glandt also breaks down what GLP-1 medications actually do, where they can help, and what they may leave unresolved—including the risks of muscle loss, inadequate protein intake, and relying on medication without addressing the patient’s broader metabolic health. Questions Answered in This Episode: • What key mindset shifts do conventionally trained physicians need to make when transitioning to a more integrated approach to medicine? • How does reframing diabetes as insulin resistance change the way a doctor practices? • What are the earliest signs of metabolic dysfunction that many clinicians miss? • Can ketogenic metabolic therapy succeed in underserved communities? • What do GLP-1 medications actually solve, and what do they leave untouched? • Where can ketogenic therapy and GLP-1 medications work together? • What has Dr. Glandt observed in patients living with both metabolic and psychiatric illness? • Where does endocrinology most need to change course? Viewers will come away with a different lens on metabolic disease, one that looks beyond glucose and weight to the biological, social, and practical factors shaping a patient’s health. More links: For Richer, for Poorer: Low-Carb Diets Work for All Incomes OwnaHealth: Reverse the course of chronic disease — for everyone. Special thanks to the sponsors of this episode: ✅ Toups and Co – Get 15% off your first order with code METABOLIC here. ✅ iRestore – Get a huge discount on the Elite and the Illumina bundle with the code LINK here. In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in! You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel ! Find us on social: Instagram Facebook YouTube LinkedIn Please keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.

  ListenShow Notes
• 

  Episode #97

  Treating PTSD When Standard Care Falls Short: A Hyperbaric Oxygen Protocol | Dr. Keren Doenyas-Barak, MD | The Metabolic Link Ep. 97

  Jun 16, 20261h 17m

  Fewer than 40% of people with PTSD respond to standard care. For the intrusive symptoms at the core of the disorder, response rates may be lower than 15%. So what options remain for patients who have not responded to existing treatments? Dr. Keren Doenyas-Barak, director of the PTSD program at the Sagol Center for Hyperbaric Medicine and Research and a faculty member at Tel Aviv University, has treated close to 1,000 civilian and military patients and led sham-controlled trials that are helping reshape how hyperbaric medicine is studied. She walks host Dr. Dominic D'Agostino through the protocol her clinic uses—60 sessions over 12 weeks, with oxygen cycled at two atmospheres—the 35% CAPS-score improvement associated with continued progress after treatment ends, and the reported two-year outcomes, including improved occupational function, roughly double the proportion of patients living with a partner, and sharp drops in benzodiazepine and cannabis use. She also details the convincing sham control her team engineered after concluding that earlier placebo arms may have delivered a physiologically active dose. Questions Answered in This Episode: What hyperbaric protocol is best supported for treatment-resistant PTSD? What does a 35% reduction in CAPS score predict about long-term recovery? Which outcomes beyond symptom scores changed most for patients? How did the team build a hyperbaric sham that patients genuinely could not detect? Which safety measures are non-negotiable in a hyperbaric PTSD clinic? Does a patient's baseline metabolic fitness predict their response to HBOT, and can the treatment affect cardiometabolic risk? A rigorous, frontline examination of what responsible hyperbaric medicine actually requires, led by a clinician helping to build its evidence base. Special thanks to the sponsors of this episode: ✅ Toups and Co – Get 15% off your first order with code METABOLIC here. ✅ iRestore – Get a huge discount on the Elite and the Illumina bundle with the code LINK here. ✅ MudWtr – Get up to 43% off + free shipping and a free rechargeable frother with code METABOLICLINK here. In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in! You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel ! Find us on social: Instagram Facebook YouTube LinkedIn Please keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.

  ListenShow Notes
• 

  Episode #96

  Inflammation and Glycation: The Two Heads of Chronic Disease | Dr. Paul Reynolds, PhD | The Metabolic Link Ep. 96

  Jun 2, 20261h 14mS0

  <p>Dr. Paul Reynolds has spent his career studying what he calls “two heads of the same beast”: inflammation and glycation — two interlocking processes that may help explain why so many chronic diseases are connected, even when they are treated as separate conditions.</p><p>Dr. Reynolds is a professor and research scientist at Brigham Young University whose NIH-funded research program studies inflammation, lung biology, glycation, and the AGE/RAGE receptor system that links metabolic and environmental stressors to disease throughout the body.</p><p>In this episode, Dr. Reynolds traces the glycation cascade from early sugar-protein reactions to advanced glycat...

  ListenShow Notes

Recent guests on The Metabolic Link. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.